🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Matthew Appleby

National Hospital for Neurology and Neurosurgery

ORCID: 0000-0001-6888-981X

Also affiliated with University College London

Materials ScienceEngineeringMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial”.

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet Neurology(2023)10.1016/s1474-4422(23)00275-2

N/A

0.867DataRank · unranked

34 citations

Michael McDermott, Thomas Blaettler, Claus Sundgreen, Anthony A. Amato, Emma Ciafaloni +74 more

A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease

Movement Disorders(2023)10.1002/mds.29450

N/A

0.633DataRank · unranked

67 citations

Matthew Appleby, Ellen Buckley, Linda Van Gelder, Benjamin H. Mullish, Matilde Sassani +14 more

Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

The Lancet Rheumatology(2023)10.1016/s2665-9913(23)00003-6

N/A

0DataRank · unranked

55 citations

Anthony A. Amato, Mazen M. Dimachkie, Hector Chinoy, Yessar Hussain, James B Lilleker +43 more